focus -WSS

focus

author：fashion 2025-09-14 21:35:53 - browse：632

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Removing probiotics from the NICU could threaten preemies' health

focus

WSS

Humana CEO Bruce Broussard to step down in 2024

How should state employee insurance handle Wegovy?

There’s no way to know how good AI health technologies are

Excited delirium, Elijah McClain, and emergency physicians

Nick Jonas talks about managing diabetes along with his career

Senate panel clears PBM, hopsital reforms

focus

focus

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA approves potent Eli Lilly obesity drug, Zepbound

Peter Hotez and the public health issue of online harassment

A revolution in caring for preterm infants

Walensky prepares to leave CDC — and Congress — behind

Sanofi CEO defends move to abandon profit guidance, boost research

New air purifier tech could be key to improving indoor air quality

STAT Executive Editor Rick Berke on STAT's 8th birthday

Medicare details structure of new drug price negotiation program

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

knowledge

FDA approves potent Eli Lilly obesity drug, Zepbound

HPV cancer vaccine study demonstrates efficacy

Victims of gun violence feel impacts long after bullet wound

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Researchers CRISPR chickens in bid to protect them from bird flu

Researchers CRISPR chickens in bid to protect them from bird flu

focus

entertainment

hotspot

focus